Thorough Future Officially Launches Thorough Copilot — Pioneering Intelligent Interactive Pathology Diagnosis

Pathological diagnosis is the “gold standard” of clinical medicine, playing a crucial role in diagnosing complex diseases such as cancer. Since the National Development and Reform Commission proposed the construction of smart hospitals in 2014, policies such as the “Healthy China 2030” Planning Outline and the “14th Five-Year Plan” for Digital Economy Development have been successively introduced, encouraging medical technology innovation and creating conditions for the digitalization and intelligentization of pathological diagnosis. With the vigorous development of large pathology models, pathological diagnosis has entered an era of advanced intelligence. A report by the China Industrial Information Security Development Research Center points out that with the rapid growth in the scale and parameter count of large model training, intelligent technologies are reaching new heights, demonstrating significant potential in the field of intelligent medical diagnosis and treatment.

In October 2024, Thorough Future released Thorough Insights 4.x—the world’s first clinical-grade large artificial intelligence model for pathology. Featuring a billion-parameter scale and an innovative combination of unsupervised, weakly supervised, and supervised learning, it provides accurate, stable, comprehensive, and rapid AI solutions for pathological diagnosis. Thorough Insights covers most histopathological diagnostic scenarios, supporting intelligent analysis of pathology in more than ten organs with high-incidence tumors, precisely locating cancerous regions and automatically completing disease subtyping. In clinical pathology applications at large hospitals, its sensitivity approaches 100% and specificity exceeds 94%; at small and medium-sized hospitals, sensitivity similarly approaches 100% while specificity exceeds 90%. Facing complex and variable diagnostic scenarios, the system demonstrates strong adaptability, serving as a stable and efficient auxiliary diagnostic tool for physicians. Furthermore, in practical pathology department applications, Thorough Insights can analyze over 1,300 small-specimen slides or 450 large-specimen slides within eight hours, significantly enhancing diagnostic efficiency in pathology departments and alleviating physicians’ workload.

As Thorough Insights leads global AI-driven histopathological diagnosis, THORUGH FUTURE officially launches Thorough Copilot—an AI-powered interactive assistant designed specifically for pathologists. This powerful synergy empowers pathologists to enhance diagnostic efficiency, optimize clinical workflows, and advance the development of precision medicine.

Thorough Copilot leverages the precise disease diagnostics of Thorough Insights and combines them with a deep understanding of whole-slide images to provide real-time histological analysis, assisting physicians in making accurate diagnoses. By integrating large language models with pathology-specific vision foundation models, Thorough Copilot offers robust real-time question-and-answer capabilities. Physicians can interact with the system regarding pathological images or clinical diagnoses, and it rapidly comprehends queries and generates responses. Additionally, Thorough Copilot features contextual memory, recording physicians’ query histories and continuously following up on case discussions to ensure the coherence and accuracy of every interaction.

Thorough Copilot can recommend further ancillary tests to physicians based on specific pathological features during the process of assisting in pathological diagnosis. For instance, when encountering challenging cases, Thorough Copilot will recommend additional immunohistochemical staining or molecular testing to facilitate further diagnosis. Furthermore, Thorough Copilot can provide personalized diagnostic and treatment recommendations by integrating information such as tumor grading and molecular testing results.

The launch of Thorough Copilot marks a new phase in pathological artificial intelligence, characterized by greater intelligence, precision, and efficiency. The close collaboration between Thorough Insights and Thorough Copilot not only drives breakthroughs in AI-powered pathology technology but also opens up new possibilities for clinical applications. It is poised to provide more efficient and precise technical support for tumor diagnosis and treatment, thereby improving therapeutic outcomes for cancer patients. Looking ahead, with the widespread application and deep promotion of large pathological models, China’s level of digital and intelligent pathology will continue to rise. This will promote the universal coverage of high-quality medical services, enabling more patients to access high-standard diagnostic and therapeutic care, and providing a solid foundation for achieving the grand vision of a Healthy China.